May/June 2019


In this Supplement

Managing the High Bleeding Risk PCI Patient

The latest thinking on DAPT guidelines and patient care.




Download a PDF of this supplement

Limitations in Identifying and Managing HBR Patients Undergoing PCI

A deficit of randomized PCI data including the high bleeding risk population makes it challenging to define the optimal management of these patients.

By Thomas Cuisset, MD

Key Factors for Clinical Decisions When Treating Patients at High Bleeding Risk

Less is more when treating high bleeding risk patients with latest-generation DESs and short DAPT duration.

By Michel Zeitouni, MD; and Gilles Montalescot, MD, PhD

Clinical Decision-Making When Treating High Bleeding Risk Patients: A Japanese Perspective

By Kazushige Kadota, MD, PhD

The Role of Stent Biomaterials In Reducing DAPT Duration

Expert commentary on the roles of technology and pharmacology.

By Hiroyuki Jinnouchi, MD; Renu Virmani, MD; and Aloke V. Finn, MD

Case Report: Antiplatelet Therapy After Complex PCI in the Anticoagulated Patient

By Michael P. Savage, MD, FACC, FSCAI, FACP; David L. Fischman, MD, FACC, FACP; and Marguerite Davis, BS, RT(R), RCIS

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.